Literature DB >> 31607367

Antibody responses to the HIV-1 envelope high mannose patch.

Christine N Daniels1, Kevin O Saunders2.   

Abstract

Neutralizing antibodies against human immunodeficiency virus subtype 1 (HIV-1) bind to its envelope glycoprotein (Env). Half of the molecular mass of Env is carbohydrate making it one of the most heavily glycosylated proteins known in nature. HIV-1 Env glycans are derived from the host and present a formidable challenge for host anti-glycan antibody induction. Anti-glycan antibody induction is challenging because anti-HIV-1 glycan antibodies should recognize Env antigen while not acquiring autoreactivity. Thus, the glycan network on HIV-1 Env is referred to as the glycan shield. Despite the challenges presented by immune recognition of host-derived glycans, neutralizing antibodies capable of binding the glycans on HIV-1 Env can be generated by the host immune system in the setting of HIV-1 infection. In particular, a cluster of high mannose glycans, including an N-linked glycan at position 332, form the high mannose patch and are targeted by a variety of broadly neutralizing antibodies. These high mannose patch-directed HIV-1 antibodies can be categorized into distinct categories based on their antibody paratope structure, neutralization activity, and glycan and peptide reactivity. Below we will compare and contrast each of these classes of HIV-1 glycan-dependent antibodies and describe vaccine design efforts to elicit each of these antibody types.
© 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antibody; Glycan; HIV-1; Neutralization; Vaccine

Mesh:

Substances:

Year:  2019        PMID: 31607367     DOI: 10.1016/bs.ai.2019.08.002

Source DB:  PubMed          Journal:  Adv Immunol        ISSN: 0065-2776            Impact factor:   3.543


  9 in total

1.  Targeted selection of HIV-specific antibody mutations by engineering B cell maturation.

Authors:  Kevin O Saunders; Kevin Wiehe; Ming Tian; Priyamvada Acharya; Todd Bradley; S Munir Alam; Eden P Go; Richard Scearce; Laura Sutherland; Rory Henderson; Allen L Hsu; Mario J Borgnia; Haiyan Chen; Xiaozhi Lu; Nelson R Wu; Brian Watts; Chuancang Jiang; David Easterhoff; Hwei-Ling Cheng; Kelly McGovern; Peyton Waddicor; Aimee Chapdelaine-Williams; Amanda Eaton; Jinsong Zhang; Wes Rountree; Laurent Verkoczy; Mark Tomai; Mark G Lewis; Heather R Desaire; Robert J Edwards; Derek W Cain; Mattia Bonsignori; David Montefiori; Frederick W Alt; Barton F Haynes
Journal:  Science       Date:  2019-12-06       Impact factor: 47.728

2.  Fab-dimerized glycan-reactive antibodies are a structural category of natural antibodies.

Authors:  Wilton B Williams; R Ryan Meyerhoff; R J Edwards; Hui Li; Kartik Manne; Nathan I Nicely; Rory Henderson; Ye Zhou; Katarzyna Janowska; Katayoun Mansouri; Sophie Gobeil; Tyler Evangelous; Bhavna Hora; Madison Berry; A Yousef Abuahmad; Jordan Sprenz; Margaret Deyton; Victoria Stalls; Megan Kopp; Allen L Hsu; Mario J Borgnia; Guillaume B E Stewart-Jones; Matthew S Lee; Naomi Bronkema; M Anthony Moody; Kevin Wiehe; Todd Bradley; S Munir Alam; Robert J Parks; Andrew Foulger; Thomas Oguin; Gregory D Sempowski; Mattia Bonsignori; Celia C LaBranche; David C Montefiori; Michael Seaman; Sampa Santra; John Perfect; Joseph R Francica; Geoffrey M Lynn; Baptiste Aussedat; William E Walkowicz; Richard Laga; Garnett Kelsoe; Kevin O Saunders; Daniela Fera; Peter D Kwong; Robert A Seder; Alberto Bartesaghi; George M Shaw; Priyamvada Acharya; Barton F Haynes
Journal:  Cell       Date:  2021-05-20       Impact factor: 41.582

3.  The Impact of Sustained Immunization Regimens on the Antibody Response to Oligomannose Glycans.

Authors:  Dung N Nguyen; Richard L Redman; Satoru Horiya; Jennifer K Bailey; Bokai Xu; Robyn L Stanfield; J Sebastian Temme; Celia C LaBranche; Shiyu Wang; Avital A Rodal; David C Montefiori; Ian A Wilson; Isaac J Krauss
Journal:  ACS Chem Biol       Date:  2020-03-09       Impact factor: 5.100

Review 4.  Strategies for induction of HIV-1 envelope-reactive broadly neutralizing antibodies.

Authors:  Wilton B Williams; Kevin Wiehe; Kevin O Saunders; Barton F Haynes
Journal:  J Int AIDS Soc       Date:  2021-11       Impact factor: 5.396

5.  Epitope convergence of broadly HIV-1 neutralizing IgA and IgG antibody lineages in a viremic controller.

Authors:  Valérie Lorin; Ignacio Fernández; Guillemette Masse-Ranson; Mélanie Bouvin-Pley; Luis M Molinos-Albert; Cyril Planchais; Thierry Hieu; Gérard Péhau-Arnaudet; Dominik Hrebík; Giulia Girelli-Zubani; Oriane Fiquet; Florence Guivel-Benhassine; Rogier W Sanders; Bruce D Walker; Olivier Schwartz; Johannes F Scheid; Jordan D Dimitrov; Pavel Plevka; Martine Braibant; Michael S Seaman; François Bontems; James P Di Santo; Félix A Rey; Hugo Mouquet
Journal:  J Exp Med       Date:  2022-03-01       Impact factor: 17.579

Review 6.  Strategies for HIV-1 vaccines that induce broadly neutralizing antibodies.

Authors:  Barton F Haynes; Kevin Wiehe; Persephone Borrrow; Kevin O Saunders; Bette Korber; Kshitij Wagh; Andrew J McMichael; Garnett Kelsoe; Beatrice H Hahn; Frederick Alt; George M Shaw
Journal:  Nat Rev Immunol       Date:  2022-08-12       Impact factor: 108.555

Review 7.  Algal and Cyanobacterial Lectins and Their Antimicrobial Properties.

Authors:  José Abel Fernández Romero; María Gabriela Paglini; Christine Priano; Adolfina Koroch; Yoel Rodríguez; James Sailer; Natalia Teleshova
Journal:  Mar Drugs       Date:  2021-12-01       Impact factor: 5.118

Review 8.  A Structural Update of Neutralizing Epitopes on the HIV Envelope, a Moving Target.

Authors:  Emma Parker Miller; Maxwell T Finkelstein; Molly C Erdman; Paul C Seth; Daniela Fera
Journal:  Viruses       Date:  2021-09-05       Impact factor: 5.048

Review 9.  The HIV Env Glycoprotein Conformational States on Cells and Viruses.

Authors:  Connie Zhao; Hongru Li; Talia H Swartz; Benjamin K Chen
Journal:  mBio       Date:  2022-03-24       Impact factor: 7.786

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.